Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 4, No. 3, 2011
Issue release date: September – December
Section title: Published: December 2011

Open Access Gateway

Case Rep Oncol 2011;4:587–591

Small Cell Carcinoma of the Tonsil Treated with Irinotecan and Cisplatin: A Case Report and Literature Review

Segawa Y.a · Nakashima T.a · Shiratsuchi H.a · Tanaka R.b · Mitsugi K.b · Komune S.a
aDepartment of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, and bDepartment of Internal Medicine, Hamanomachi General Hospital, Fukuoka, Japan
email Corresponding Author

Dr. Yuichi Segawa

Department of Otorhinolaryngology, Graduate School of Medical SciencesKyushu University, Maidashi 3-1-1, Higashi-ku

Fukuoka 812-8582 (Japan)

Tel. +81 92 642 5668, E-Mail segayuu@qent.med.kyushu-u.ac.jp

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


We report a rare case of extrapulmonary small cell carcinoma arising in the palatine tonsil treated by combined chemotherapy with irinotecan/cisplatin following irradiation therapy. This chemotherapy regimen was recently found to be effective for small cell lung carcinoma. Our case is the first report of combined irinotecan/cisplatin chemotherapy to treat extrapulmonary small cell carcinoma of the oropharynx.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: December 2011

Published online: December 07, 2011
Issue release date: September – December

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 0

ISSN: (Print)
eISSN: 1662-6575 (Online)

For additional information: http://www.karger.com/CRO

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.